Analytical and bioanalytical contract service provider SGS has appointed Haris Jamil as biologics manager of its recently expanded biopharmaceutical testing facility in Lincolnshire, IL. The $1.7 million investment to expand its North American capabilities was announced in September 2018.
 
Dr. Jamil, who has over 25 years’ experience in the life science industry, will be responsible for overseeing the newly created biologics department at the 58,000 square foot facility. He joins SGS from global healthcare company Fresenius Kabi, where he held the position of senior manager within analytical development.
 
“Haris joins SGS at an exciting time for the company and brings a wealth of experience and leadership to SGS. We are pleased to have him play an integral part in the launch and delivery of our new biologics testing services at the facility and lead the way in ensuring outstanding service for our biopharmaceutical clients.”
 
Dr. Jamil received his Ph.D. in biochemistry from the University of London and has over 15 years’ direct experience leading analytical development and product development laboratories, as well as supervising technical staff in supporting manufacturing, stability testing, release testing, clinical trials, regulatory submission and launch of small and large peptides and biologics therapeutics.